theraflu 500 mg/100 mg/6,1 mg trde kapsule
glaxosmithkline consumer healthcare (uk) trading limited - fenilefrin, gvaifenezin, paracetamol - kapsula, trda - fenilefrin 5 mg / 1 kapsula; gvaifenezin 100 mg / 1 kapsula; paracetamol 500 mg / 1 kapsula - paracetamol, kombinacije brez psiholeptikov
theraflu 1000 mg/200 mg/12,2 mg prašek za peroralno raztopino
glaxosmithkline consumer healthcare (uk) trading limited - fenilefrin; gvaifenezin; paracetamol - prašek za peroralno raztopino - fenilefrin 10 mg / 1 g gvaifenezin200 mg / 1 g paracetamol1000 mg / 1 g; gvaifenezin 200 mg / 1 g paracetamol1000 mg / 1 g; paracetamol 1000 mg / 1 g - paracetamol, kombinacije brez psiholeptikov
theraflu 500 mg/10 mg/200 mg v 30 ml sirup
glaxosmithkline consumer healthcare (uk) trading limited - fenilefrin; gvaifenezin; paracetamol - sirup - fenilefrin 8,2 mg / 30 ml gvaifenezin200 mg / 30 ml paracetamol500 mg / 30 ml; gvaifenezin 200 mg / 30 ml paracetamol500 mg / 30 ml; paracetamol 500 mg / 30 ml - paracetamol, kombinacije brez psiholeptikov
tifol 0,4 mg filmsko obložene tablete
krka, d.d., novo mesto - folna kislina (vitamin b9) - filmsko obložena tableta - folna kislina (vitamin b9) 0,4 mg / 1 tableta - folna kislina
cosentyx
novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunosupresivi - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriatični arthritiscosentyx, samostojno ali v kombinaciji z metotreksatom (mtx), je primerna za zdravljenje aktivnega psoriatičnega artritisa pri odraslih bolnikih, kadar je odgovor na prejšnje bolezni spreminjanje anti revmatičnih drog (dmard) terapija je bila neustrezna. aksialni spondyloarthritis (axspa)ankilozirajoči spondilitis (kot, radiografski osno spondyloarthritis)cosentyx je primerna za zdravljenje aktivnega ankilozirajoči spondilitis pri odraslih, ki so se odzvali neustrezno konvencionalne terapije. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.
actalipid 20 mg filmsko obložene tablete
actavis group ptc ehf. - simvastatin - filmsko obložena tableta - simvastatin 20 mg / 1 tableta - simvastatin
actalipid 40 mg filmsko obložene tablete
actavis group ptc ehf. - simvastatin - filmsko obložena tableta - simvastatin 40 mg / 1 tableta - simvastatin
actalipid 10 mg filmsko obložene tablete
actavis group ptc ehf. - simvastatin - filmsko obložena tableta - simvastatin 10 mg / 1 tableta - simvastatin
advantan 1 mg/g krema
bayer d.o.o. - metilprednizolonaceponat - krema - metilprednizolonaceponat 1 mg / 1 g - metilprednizolonaceponat
advantan 1 mg/g krema
bayer d.o.o. - metilprednizolonaceponat - krema - metilprednizolonaceponat 1 mg / 1 g - metilprednizolonaceponat